- Home
- LAES vs ICU Comparison
LAES vs ICU Comparison
Compare LAES & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAES
- ICU
- Stock Information
- Founded
- LAES 2022
- ICU 2018
- Country
- LAES Switzerland
- ICU United States
- Employees
- LAES N/A
- ICU N/A
- Industry
- LAES Semiconductors
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- LAES Technology
- ICU Health Care
- Exchange
- LAES Nasdaq
- ICU Nasdaq
- Market Cap
- LAES 10.7M
- ICU 10.3M
- IPO Year
- LAES N/A
- ICU N/A
- Fundamental
- Price
- LAES $2.33
- ICU $2.00
- Analyst Decision
- LAES Strong Buy
- ICU
- Analyst Count
- LAES 1
- ICU 0
- Target Price
- LAES $1.75
- ICU N/A
- AVG Volume (30 Days)
- LAES 49.6M
- ICU 24.8K
- Earning Date
- LAES 09-25-2024
- ICU 11-13-2024
- Dividend Yield
- LAES N/A
- ICU N/A
- EPS Growth
- LAES N/A
- ICU N/A
- EPS
- LAES N/A
- ICU N/A
- Revenue
- LAES $20,135,000.00
- ICU $68,000.00
- Revenue This Year
- LAES N/A
- ICU N/A
- Revenue Next Year
- LAES N/A
- ICU $344.44
- P/E Ratio
- LAES N/A
- ICU N/A
- Revenue Growth
- LAES N/A
- ICU N/A
- 52 Week Low
- LAES $0.29
- ICU $1.70
- 52 Week High
- LAES $3.95
- ICU $42.93
- Technical
- Relative Strength Index (RSI)
- LAES 83.63
- ICU 39.05
- Support Level
- LAES $0.35
- ICU $1.70
- Resistance Level
- LAES $3.46
- ICU $2.04
- Average True Range (ATR)
- LAES 0.30
- ICU 0.19
- MACD
- LAES 0.27
- ICU 0.01
- Stochastic Oscillator
- LAES 76.85
- ICU 33.33
About LAES SEALSQ Corp
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. Its vaultIC range offers a complete set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.